● Recruiting

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Condition: Severe Tricuspid Regurgitation · Sponsor: Medtronic Cardiovascular

PhaseNA

Planned participants1186

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

This description comes directly from the study's public registry record.

Talk to the study team

Amber St Martin · 612-380-5637 · rs.pathfinder@medtronic.com

Always discuss trial participation with your own doctor first.

Locations (4)

Abrazo Arizona Heart Hospital	Phoenix, Arizona, United States	Recruiting
Los Robles Hospital & Medical Center	Thousand Oaks, California, United States	Recruiting
Abbott Northwestern Hospital	Minneapolis, Minnesota, United States	Recruiting
The Christ Hospital	Cincinnati, Ohio, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07321899